Historic achievement: FDA approval of Abeona Therapeutics’ ZEVASKYN accelerates momentum and expands treatment options for the EB community.
EB Research Partnership ("EBRP") invested in the work that led to ZEVASKYN at Stanford University under their pioneering Venture Philanthropy Model. This approval marks a historic moment for the EB